(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IC31

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

IC31

ST13

US500000079017956

Class

1, 5, 42

Filing

79017956

Registration

3199067

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

01/30/2026

Trademark type

Combined

Nice classes

1, 5, 42

Filing date

02/10/2005

Registration date

01/16/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/02/2017

Last transaction

01/30/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

5

Owner type

16

Owner location

Vienna, AT

Examiner

BELZER, LYDIA M

Law office

L80

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Valneva Austria GmbH
INTERCELL AG

Representatives

Lawrence E. Abelman Abelman Frayne and Schwab

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals and chemical preparations for use in immunostimulants and vaccines; biological preparations in the nature of biological tissuebloodstem cellsumbilical cords and placentas for scientific and medical research use related to use in immunostiumulants and vaccines

Class 5

Pharmaceutical preparationsimmunostimulants and vaccines; veterinary preparationsimmunostimulants and vaccines; adjuvant for use with vaccines

Class 42

Scientific research and development in the nature of the development of medical diagnosis in the fields of immunostiumulants and vaccines; chemicalmedicalpharmaceutical and bacteriological research in the fields of immunostimulants and vaccines

Publications

History of USPTO decisions and trademark events.

49 publications found

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

01/29/2026

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

01/16/2026

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

01/08/2026

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/23/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/15/2022

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

03/22/2021

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

12/18/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/18/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/04/2019

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/02/2017

71AG

REGISTERED-SEC.71 ACCEPTED

06/02/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/31/2017

ES71

TEAS SECTION 71 RECEIVED

01/17/2017

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/26/2015

CHLD

CHANGE OF OWNER RECEIVED FROM IB

11/06/2014

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED

01/08/2013

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

01/08/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/08/2013

715F

REGISTERED - SEC. 71 & SEC. 15 FILED

12/13/2012

ES75

TEAS SECTION 71 & 15 RECEIVED

12/13/2012

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/02/2008

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/20/2007

FIMP

FINAL DISPOSITION PROCESSED

08/20/2007

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/09/2007

R.PR

REGISTERED-PRINCIPAL REGISTER

01/16/2007

PUBO

PUBLISHED FOR OPPOSITION

10/31/2006

NPUB

NOTICE OF PUBLICATION

10/11/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/18/2006

ALIE

ASSIGNED TO LIE

09/15/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/14/2006

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/13/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/05/2006

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/05/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/05/2006

CPRA

PRIORITY ACTION MAILED

08/16/2006

CPRA

PRIORITY ACTION WRITTEN

08/16/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

07/27/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/17/2006

MAIL

PAPER RECEIVED

07/17/2006

RFNT

REFUSAL PROCESSED BY IB

02/03/2006

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/12/2006

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/10/2006

CNRT

NON-FINAL ACTION WRITTEN

01/09/2006

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

12/28/2005

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/28/2005

CNRT

NON-FINAL ACTION WRITTEN

12/27/2005

DOCK

ASSIGNED TO EXAMINER

12/19/2005

NWAP

NEW APPLICATION ENTERED

12/19/2005

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/15/2005

Continuous trademark protection

Get notified about every new filing that threatens IC31 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.